Use of tanning potential as a predictor for prostate cancer risk in African-American men

In Vivo

Volumn 28, Issue 6, 2014, Pages 1181-1188

  Beyene, Desta ^a   Daremipouran, Mohammad ^a   Apprey, Victor ^b   Williams, Robert ^c   Ricks Santi, Luisel ^d   Kassim, Olakunle O ^b   Naab, Tammey J ^c   Kanaan, Yasmine M ^a,b   Copeland, Robert L ^a,b  

^a HOWARD UNIVERSITY CANCER CENTER   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HOWARD UNIVERSITY HOSPITAL   (United States)

^d HAMPTON UNIVERSITY   (United States)

Author keywords

African American men; Prostate cancer; Ultraviolet exposure; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CUTANEOUS PARAMETERS; ENVIRONMENTAL FACTOR; HUMAN; LEATHER INDUSTRY; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RADIATION EXPOSURE; RISK FACTOR; SKIN COLOR; SUNLIGHT; TANNING POTENTIAL; ULTRAVIOLET RADIATION; UNITED STATES; VITAMIN D DEFICIENCY; BLOOD; METABOLISM; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK; SUNTAN; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK; SUNLIGHT; SUNTAN; ULTRAVIOLET RAYS; VITAMIN D;

EID: 84918593047     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Center for Disease Control and Prevention. Incidence and Mortality Web-based Report. www.cdc.gov/cancer/prostate/statistics/state.htm, August 2014.
2. Williams H and Powell I: Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Cancer Epidemiology, Methods in Molecular Biology 472: 439-453, 1990.
3. Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, Dipaola RS, and Lu-Yao GL: Contemporary Risk Profile of Prostate Cancer in the United States JNCI J Natl Cancer Inst 101(18): 1280-1283, 2009.
4. Rodriguez D: Prostate cancer risk in African-American men, www.everydayhealth.com, August 2014.
5. Grant, WB: Geographic variation of prostate cancer mortality rates in the United States: implications for prostate cancer risk related to vitamin D. International Journal of Cancer 111(3): 470-471, 2004.
6. Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC and Potosky AL: Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study. NCI J Natl Cancer Inst 93 (5): 388-395, 2001.
7. Robbins AS and Whittemore. Race, Prostate Cancer Survival, and Membership in a Large Health Maintenance Organization. JNCI J Natl Cancer Inst 90(13): 986-990, 1998.
8. Tseng M, Giri V, Bruner DB and Tseng GE: Prevalence and correlates of vitamin D status in African American Men. BMC Public Health, 9-191, 2009.
9. Ginde AA, Liu MC and Camargo CA Jr.: Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169(6): 626-632, 2009.
10. van der Rhee H, Coebergh JW and Vries ED: Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. European Journal of Cancer Prevention, 18: 458-475, 2009.
11. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH and Orentreich N: Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiology Biomarkers and Prevention 2(5): 467-472, 1993.
12. Yetley EA: Assessing the vitamin D status of the US population. Am J Clin Nutr 88: 558S-564S, 2008.
13. Shaw NJ and Pal BR: Vitamin D deficiency in UK Asian families: activating a new concern. Arch Dis Child 86: 147-149, 2002.
14. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C and Persad R: The risk of prostate cancer amongst black men in the United Kingdom: the process cohort study. European Urology 53 (1): 99-105, 2008.
15. Holick MF: The vitamin D epidemic and its health consequences. J Nutr 135: 2739S-2748S, 2005.
16. Ahonen MH, Tenkanen L, Teppo L, Hakama M and Tuohimaa P: Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes and Control 11(9): 847-852, 2000.
17. Luscombe CJ, Fryer AA, French ME, Liu S, Saxby MF, Jones PW and Strange RC: Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. The Lancet 358 (9282): 641-642, 2001.
18. John EM, Dreon DM, Koo J and Schwartz GG: Residential sunlight exposure is associated with a decreased risk of prostate cancer. Journal of Steroid Biochemistry & Molecular Biology 89-90(1-5): 549-552, 2004.
19. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Fryer AA and Strange RC: Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer: Environmental and Molecular Mutagenesis 43(2): 121-127, 2004.
20. Rajakumar K, Greenspan SL, Thomas SB and Hollick MF: Solar ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health 97: 1746-1754, 2007.
21. Gilbert R, Metcalfe C, Oliver SE, Whiteman DC, Bain C, Ness A, Donovan J, Hamdy F, Neal DE, Lane JA and Martin RM: Life course sun exposure and risk of prostate cancer: populationbased nested case-control study and meta-analysis. International Journal of Cancer 125(6): 1414-1423, 2009.
22. Waltz P and Chodick G: International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urologic Oncology 25(1): 85, 2007.
23. MacLaughlin J and Holick Mf: Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76: 1536-1538, 1985.
24. Colli JL and Colli A: International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urologic Oncology 24(3): 184-194, 2006.
25. Hanchette CL and Schwartz GG: Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70(12): 2861-2869, 1992.
26. Park SY, Murphy SP, Wilkens LR, Stram DO, Henderson BE and Kolonel LN: Calcium, vitamin D, and dairy product intake and prostate cancer risk: the multiethnic cohort study. American Journal of Epidemiology 166(11): 1259-1269, 2007
27. Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D and Thompson IM: Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. American Journal of Epidemiology 172(5): 566-577, 2010.
28. Huncharek M, Muscat J and Kupelnick B: Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies. Nutrition and Cancer 60(4): 421-441, 2008.
29. Kanaan YM, Beyene D and Daremipouran M: Association of cumulative ultraviolet radiation exposure with prostate cancer risk in a case-control study of African-American men. The Open Prostate Cancer Journal 5: 8-14, 2012.
30. McCarty CA, Sunlight exposure assessment: Can we accurately assess vitamin D exposure from sunlight questionaires ? Am J Clin Nutr 87(4): 1097-1015, 2008.
31. Humayun Q, Iqbal R, Azam I, Khan AH, Siddiqui AR and Baig-Ansari N: Development and validation of sunlight exposure measurement questionnaire (SEM-Q) for use in adult population residing in Pakistan. BioMed Central Public Health 12: 421-434, 2012.
32. Nordlund JJ, Boissy RE, Hearing VJ, King RA and Ortonne JP: The pigmentary system. In: Nordlund JJ, Ortonne JP (eds.). The Normal Color of Human Skin. First edition. New York: Oxford University Press; pp. 475-478, 1998.
33. Shriver MD and Esteban JB: Comparison of narrow-band reflectance spectroscopy and tristimulus colorimetry for measurements of skin and hair color in persons of different biological ancestry. American Journal of Physical Anthropology. 112: 17-27, 2000.
34. Jung-Hun Park and Mu-Hyoung Lee: A Study of skin color by melanin index according to site, gestational age, birth weight and season of birth in Korean neonate. Korean Med Sci 20(1): 105-108, 2005.
35. Westerhof W1, Estevez-Uscanga O, Meens J, Kammeyer A, Durocq M and Cario I: The relation between constitutional skin color and photosensitivity estimated from UV-induced erythema and pigmentation dose-response curves. J Invest Dermatol 94(6): 812-816, 1990.
36. Carter GD: Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 12(1): 19-28, 2011.
37. Laaksi IT, Ruohola JP, Ylikomi TJ, Auvinen A, Haataja RI, Pihlajamäki HK and Tuohimaa PJ: Association between serum 25(OH)D concentrations and bone stress fractures in Finnish young men. J Bone Miner Res 9: 1483-8, 2006.
38. Ellis PD: The Essential Guide to Effect Sizes: Statistical Power, Meta-analysis, and the Interpretation of Research Results. Cambridge University Press, New York, NY, USA, 2010.
39. nd Ed). Lawrence Earlbaum Associates Hillsdale, NJ, 1988.
40. Cohen J, Cohen P, West SG and Aiken LS: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. Third edition. Lawrence Erlbaum Associates, Mahwah, NJ, 2003.
41. Soper DS: R-square Confidence Interval calculator (online software). http://www.danielsoper.com/statcalc, August 2014
42. Soper DS (2013)"A prior sample size calculator for multiple Regression (online software). http://www.danielsoper.com/statcalc, August 2014.
43. Colli JL and Grant WB: Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States. Urology 71(3): 531-535, 2008.
44. Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL and Ma J: A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Medicine 4(3): article 103, 2007.
45. Tretli S, Hernes E, Berg JB, Hestvik UE and Robsahm TE: Association between serum 25(OH)D and death from prostate cancer. British Journal of Cancer 100(3): 450-454, 2009.
46. Braun MM, Helzlsouer KJ, Hollis BW and Comstock GW: Prostate cancer and prediagnostic levels of serum vitamin D metabolites, Maryland, United States, Cancer Causes and Control 6 (3): 235239, 1995.
47. Gandini S1, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P and Autier P: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer 128(6): 1414-1424, 2011.
48. Barnett MC, Nielson CM and Shannon J: Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes and Control 21 (8): 1297-1303, 2010.
49. Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM and Hayes RB: Serum vitamin D concentration and prostate cancer risk: a nested case-control study. Journal of the National Cancer Institute 100(11): 796-804, 2008.
50. Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH and Hunter DJ: Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiology Biomarkers and Prevention 7(5): 385-390, 1998.